Durvalumab trials for Stage IIIB Lung Cancer AJCC v8

All Durvalumab trials · All Stage IIIB Lung Cancer AJCC v8 trials

Phase breakdown

Recruiting trials studying Durvalumab for Stage IIIB Lung Cancer AJCC v8

• Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
  NCT06498635 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 279 locations
• Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
  NCT07288034 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 13 locations
• Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 Therapy
  NCT04892953 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials study Durvalumab for Stage IIIB Lung Cancer AJCC v8?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.